Spain: First vaccines purchased to combat bluetongue fever

Published 2024년 9월 18일

Tridge summary

Bluetongue disease, caused by serotype 3 of the bluetongue virus, has been detected in three sheep farms in Évora, Portugal, leading to concerns for the health of flocks in the Iberian Peninsula, particularly in Almería, Spain. To prevent the spread of the disease, which can cause up to 25% mortality in infected animals, the Spanish government is expediting the distribution of vaccines and has temporarily halted the movement of cattle and sheep between Spain and Portugal. The disease, which was first identified in Tunisia in 2018 and has since spread across Europe, does not affect humans.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

It first arrived in Portugal and now both the Government and the Junta de Andalucía are preparing for its extension to the rest of the Iberian Peninsula. It is serotype 3 of bluetongue, better known as bluetongue disease; a virus that is transmitted between cattle and sheep, causing severe clinical symptoms and high mortality, as up to 25% of infected specimens can die. The Official Veterinary Services of the neighbouring country have recently detected the disease in three sheep farms located in the Region of Évora, very close to the border with Spain. Along the same lines, there are suspicions about other nearby farms that could also be infected and which, in fact, are currently in the process of confirmation. Vaccines as soon as possible Given the circumstances, the procedures have been expedited to proceed with the distribution of the doses and thus protect the flocks of the province of Almería, where in May 2024 there were 3,156 sheep with dairy aptitude. To begin with the ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.